CS
Chris Schott JP Morgan Latest Price Targets & Analyst Ratings
Main Sector
Healthcare
Ratings Past Year
29
Avg Return
Past Year
Past Year
8.1%
Success Rate
Past Year
Past Year
0
%
Rating Distribution
Past Year
Positive
82.6%
Neutral
13%
Negative
4.3%
Past Week
Past Month
Past 3 Months
Past 6 Months
Past Year
All Time
Positive
Neutral
Negative
Mega Cap
Over $200B
Large Cap
$10B to $200B
Mid Cap
$2B to $10B
Small Cap
$250M to $2B
Micro Cap
Under $250M
Healthcare
Healthcare
Biotechnology
Diagnostics & Research
Drug Manufacturers - General
Drug Manufacturers - Specialty & Generic
| Stock | Rating | Price Target |
Upside Downside |
Ratings 1 Year |
Avg Return 1 Year |
Success Rate 1 Year | Date | |
|---|---|---|---|---|---|---|---|---|
|
Neutral
Maintained
| $250 |
6%
upside
| 1 | – |
–
| 5 Mar ‘26 3 months ago |
|
|
|
Overweight
Maintained
| $28 |
15%
upside
| 2 | +6.7% |
0
%
| 19 Feb ‘26 3 months ago |
|
|
|
Overweight
Maintained
| $1,300 |
15%
upside
| 4 | +13% |
0
%
| 5 Feb ‘26 4 months ago |
|
|
|
Overweight
Maintained
| $950 |
54%
upside
| 4 | +7.1% |
0
%
| 2 Feb ‘26 4 months ago |
|
|
|
Overweight
Maintained
| $35 |
4%
upside
| 4 | +15% |
0
%
| 16 Dec ‘25 6 months ago |
|
|
|
Neutral
Maintained
| $18 |
68%
upside
| 3 | -36% |
0
%
| 15 Dec ‘25 6 months ago |
|
|
|
Underweight
Maintained
| $12 |
11%
downside
| 1 | +18% |
0
%
| 11 Nov ‘25 7 months ago |
|
|
|
Overweight
Maintained
| $200 |
150%
upside
| 1 | -5.3% |
0
%
| 5 Nov ‘25 7 months ago |
|
|
|
Overweight
Maintained
| $775 |
36%
upside
| 2 | +7.8% |
0
%
| 4 Nov ‘25 7 months ago |
|
|
|
Overweight
Maintained
| $260 |
17%
upside
| 2 | +1% |
0
%
| 3 Nov ‘25 7 months ago |
|
|
|
Overweight
Maintained
| $150 |
21%
upside
| 3 | +10% |
0
%
| 31 Oct ‘25 7 months ago |
|
|
|
Overweight
Maintained
| $14 |
14%
downside
| 1 | +23% |
0
%
| 16 Sep ‘25 9 months ago |
|